Literature DB >> 9372189

Autokinase activity of alpha-crystallin inhibits its specific interaction with the DOTIS element in the murine gamma D/E/F-crystallin promoter in vitro.

D Pietrowski1, J Graw.   

Abstract

In a previous report we demonstrated the in vitro interaction of alpha-crystallin with an element downstream of the transcriptional initiation site (DOTIS) of the murine gamma E-crystallin promoter (Pietrowski et al., 1994, Gene 144, 171-178). The aim of the present study was to investigate the influence of phosphorylation on this particular interaction. We could demonstrate that the autophosphorylation of alpha-crystallin leads to a complete loss of interaction with the DOTIS element, however, PKA-dependent phosphorylation of alpha-crystallin is without effect on the interaction. It is hypothesized that the autophosphorylation of alpha-crystallin might be involved in regulatory mechanisms of the murine gamma D/E/F-crystallin gene expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9372189

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  3 in total

1.  Antagonistic action of Six3 and Prox1 at the gamma-crystallin promoter.

Authors:  J Lengler; E Krausz; S Tomarev; A Prescott; R A Quinlan; J Graw
Journal:  Nucleic Acids Res       Date:  2001-01-15       Impact factor: 16.971

2.  Transcriptional burst fraction and size dynamics during lens fiber cell differentiation and detailed insights into the denucleation process.

Authors:  Saima Limi; Adrien Senecal; Robert Coleman; Melissa Lopez-Jones; Peng Guo; Christina Polumbo; Robert H Singer; Arthur I Skoultchi; Ales Cvekl
Journal:  J Biol Chem       Date:  2018-06-29       Impact factor: 5.486

3.  Probing the changes in gene expression due to α-crystallin mutations in mouse models of hereditary human cataract.

Authors:  Usha P Andley; Eric Tycksen; Brittney N McGlasson-Naumann; Paul D Hamilton
Journal:  PLoS One       Date:  2018-01-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.